MEGAN SULIGOY: Open Payments
NPI 1326358367 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 28 payments from 13 companies in 2025. Trend: 2023 $113 · 2024 $524 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Novo Nordisk Inc | 4 | $83 |
| Dexcom, Inc. | 2 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 2 | $43 |
| Exact Sciences Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: UBRELVY, Dexcom G6 Transmitter, JARDIANCE, Auvelity, Veozah, The Cologuard Plus Collection Kit, MOUNJARO, Ozempic.
Industry payments across IL — which companies pay providers there.
